| Identification | |
| Name: | Pyrido[3',2':4,5]imidazo[1,2-a]pyridin-2-amine,6-methyl- |
| Synonyms: | Dipyrido[1,2-a:3',2'-d]imidazol-2-amine,6-methyl- (9CI); 2-Amino-6-methyldipyrid[1,2-a:3',2'-d]imidazole;2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole; Glu-P 1 |
| CAS: | 67730-11-4 |
| Molecular Formula: | C11H10 N4 |
| Molecular Weight: | 198.25 |
| InChI: | InChI=1/C11H10N4.ClH.H2O/c1-7-3-2-6-15-10(7)13-8-4-5-9(12)14-11(8)15;;/h2-6H,1H3,(H2,12,14);1H;1H2 |
| Molecular Structure: | ![(C11H10N4) Dipyrido[1,2-a:3',2'-d]imidazol-2-amine,6-methyl- (9CI); 2-Amino-6-methyldipyrid[1,2-a:3',2'-d]imida...](https://img1.guidechem.com/chem/e/dict/187/67730-11-4.jpg) |
| Properties | |
| Flash Point: | 173.8°C |
| Boiling Point: | 363.7°Cat760mmHg |
| Density: | 1.41g/cm3 |
| Specification: |
2-Amino-6-methyldipyrido(1,2-a:3',2'-d)imidazole (CAS.67730-11-4) also can be called 6-Methylpyrido[3',2':4,5]imidazo[1,2-a]pyridin-2-amine ; Imidazo[1,2-a:5,4-b']dipyridin-2-amine, 6-methyl- and; 6-methylimidazo[1,2-a:5,4-b']dipyridin-2-amine . |
| Report: |
IARC Cancer Review: Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 (1987),p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 40 (1986),p. 223.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . |
| Flash Point: | 173.8°C |
| Storage Temperature: | Store at room temperature |
| Sensitive: | Light Sensitive |
| Usage: | A mutagenic component isolated from L-glutamic acid pyrolysate |
| Safety Data | |
 |
|
